Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?

OBJECTIVE: To explore whether electrochemiluminescence (ECL) assays can help improve prediction of time to type 1 diabetes in the TrialNet autoantibody-positive population. RESEARCH DESIGN AND METHODS: TrialNet subjects who were positive for one or more autoantibodies (microinsulin autoantibody, GAD...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Diabetes Care
Asıl Yazarlar: Fouts, Alexandra, Pyle, Laura, Yu, Liping, Miao, Dongmei, Michels, Aaron, Krischer, Jeffrey, Sosenko, Jay, Gottlieb, Peter, Steck, Andrea K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Diabetes Association 2016
Konular:
Epidemiology/Health Services Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5033080/
https://ncbi.nlm.nih.gov/pubmed/27456836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc16-0302
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller